Variant report
Variant | nsv875524 |
---|---|
Chromosome Location | chr2:186206092-186239607 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs850882 | chr2:186206092-186206093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs147927717 | chr2:186206135-186206136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576286771 | chr2:186206163-186206164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544134651 | chr2:186206350-186206351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs850883 | chr2:186206370-186206371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs850884 | chr2:186206392-186206393 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs544763925 | chr2:186206431-186206432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562999835 | chr2:186206435-186206436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564969867 | chr2:186206483-186206484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189308319 | chr2:186206526-186206527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181350267 | chr2:186206538-186206539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs850885 | chr2:186206558-186206559 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs186304281 | chr2:186206578-186206579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190532590 | chr2:186206611-186206612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531499245 | chr2:186206643-186206644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551703981 | chr2:186206685-186206686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566949967 | chr2:186206697-186206698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534399669 | chr2:186206702-186206703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546255353 | chr2:186206714-186206715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114881436 | chr2:186206757-186206758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs850886 | chr2:186206801-186206802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs538792262 | chr2:186206866-186206867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547210669 | chr2:186206902-186206903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181550427 | chr2:186206925-186206926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375048186 | chr2:186206969-186206970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554531617 | chr2:186206974-186206975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116485904 | chr2:186207090-186207091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537320809 | chr2:186207099-186207100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559239725 | chr2:186207133-186207134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577485788 | chr2:186207151-186207152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145851749 | chr2:186207172-186207173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138549094 | chr2:186207255-186207256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572131079 | chr2:186207321-186207322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542784398 | chr2:186207326-186207327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368730396 | chr2:186207333-186207334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560865105 | chr2:186207337-186207338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531366397 | chr2:186207365-186207366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11687947 | chr2:186207375-186207376 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs548816629 | chr2:186236810-186236811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572698529 | chr2:186236820-186236821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191742417 | chr2:186236834-186236835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376970066 | chr2:186236842-186236843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74726003 | chr2:186236855-186236856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556005852 | chr2:186236889-186236890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577550763 | chr2:186236932-186236933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538426725 | chr2:186236939-186236940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553595541 | chr2:186236940-186236941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181839677 | chr2:186236951-186236952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34831915 | chr2:186236955-186236956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572539739 | chr2:186236973-186236974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186203600-186207400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:186236800-186237200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr2:186236800-186237800 | Enhancers | Adipose Nuclei | Adipose |
4 | chr2:186237200-186237600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr2:186237200-186237600 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr2:186237600-186238000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr2:186237600-186238600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
8 | chr2:186238000-186238200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr2:186239200-186239400 | Enhancers | Muscle Satellite Cultured Cells | -- |